BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2551670)

  • 1. Post-transcriptional mechanisms of deregulation of MYC following conversion of a human B cell line by Epstein-Barr virus.
    Lacy J; Summers WP; Summers WC
    EMBO J; 1989 Jul; 8(7):1973-80. PubMed ID: 2551670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification and deregulation of MYC following Epstein-Barr virus infection of a human B-cell line.
    Lacy J; Summers WP; Watson M; Glazer PM; Summers WC
    Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5838-42. PubMed ID: 3039510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of the lymphoma line "BJAB" by Epstein-Barr virus into phenotypically altered sublines is accompanied by increased c-myc mRNA levels.
    Wennborg A; Aman P; Saranath D; Pear W; Sümegi J; Klein G
    Int J Cancer; 1987 Aug; 40(2):202-6. PubMed ID: 3038758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization.
    Knutson JC
    J Virol; 1990 Jun; 64(6):2530-6. PubMed ID: 2159528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E
    J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes.
    Finke J; Fritzen R; Ternes P; Trivedi P; Bross KJ; Lange W; Mertelsmann R; Dölken G
    Blood; 1992 Jul; 80(2):459-69. PubMed ID: 1378321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
    Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
    Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus type 1 infection of isogenic Epstein-Barr virus genome-negative and -positive Burkitt's lymphoma-derived cell lines.
    Leinbach SS; Summers WC
    J Virol; 1979 Apr; 30(1):248-54. PubMed ID: 225521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-IgM-mediated regulation of c-myc and its possible relationship to apoptosis.
    Kaptein JS; Lin CK; Wang CL; Nguyen TT; Kalunta CI; Park E; Chen FS; Lad PM
    J Biol Chem; 1996 Aug; 271(31):18875-84. PubMed ID: 8702548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of c-fgr proto-oncogene expression in Burkitt's lymphoma cells: effect of interferon treatment and relationship to EBV status and c-myc mRNA levels.
    Sharp NA; Luscombe MJ; Clemens MJ
    Oncogene; 1989 Aug; 4(8):1043-6. PubMed ID: 2548145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogene expression in isogenic, EBV-positive and -negative Burkitt lymphoma cell lines.
    Glazer PM; Summers WC
    Intervirology; 1985; 23(2):82-9. PubMed ID: 2984143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular forms of human NOTCH1 functionally activate essential Epstein-Barr virus major latent promoters in the Burkitt's lymphoma BJAB cell line but repress these promoters in Jurkat cells.
    Cotter M; Callahan J; Aster J; Robertson E
    J Virol; 2000 Feb; 74(3):1486-94. PubMed ID: 10627560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
    Lear AL; Rowe M; Kurilla MG; Lee S; Henderson S; Kieff E; Rickinson AB
    J Virol; 1992 Dec; 66(12):7461-8. PubMed ID: 1331531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of c-fgr proto-oncogene expression in Epstein-Barr virus infected B-cell lines.
    Patel M; Leevers SJ; Brickell PM
    Int J Cancer; 1990 Feb; 45(2):342-6. PubMed ID: 2154410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
    Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated expression of c-myc in lymphoblastoid cells does not support an Epstein-Barr virus latency III-to-I switch.
    Pajic A; Polack A; Staege MS; Spitkovsky D; Baier B; Bornkamm GW; Laux G
    J Gen Virol; 2001 Dec; 82(Pt 12):3051-3055. PubMed ID: 11714983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics and Transcriptomics of BJAB Cells Expressing the Epstein-Barr Virus Noncoding RNAs EBER1 and EBER2.
    Pimienta G; Fok V; Haslip M; Nagy M; Takyar S; Steitz JA
    PLoS One; 2015; 10(6):e0124638. PubMed ID: 26121143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
    Price AM; Messinger JE; Luftig MA
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene.
    Zimber-Strobl U; Suentzenich KO; Laux G; Eick D; Cordier M; Calender A; Billaud M; Lenoir GM; Bornkamm GW
    J Virol; 1991 Jan; 65(1):415-23. PubMed ID: 1845900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region.
    Marquitz AR; Mathur A; Edwards RH; Raab-Traub N
    J Virol; 2015 Nov; 89(22):11256-68. PubMed ID: 26311882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.